67 Results for "

Ovariectomized

" in MedChemExpress (MCE) Product Catalog:
Products (67)

67 Results for "Ovariectomized" in MCE Product Catalog:

Cat. No.: HY-187614
CAS No.: 1597-68-8
Target:  

Cytochrome P450

Research Areas:  

Endocrinology

6α-Fluorotestosterone is a non-aromatizable aromatase inhibitor, with IC50 values of 115 nM and 580 nM against human and rat aromatase, respectively. 6α-Fluorotestosterone binds to the substrate site of human aromatase P450arom with a Ki of 150 nM, but is not aromatized into estrogen. In vivo, 6α-Fluorotestosterone maintains sexual behavior in castrated male rats (with an effect comparable to that of testosterone), induces defeminization of sexual development, and inhibits nuclear translocation of hypothalamic estrogen receptors; its pro-mating effect is blocked by the aromatase inhibitors ATD and Fadrozole (HY-14247A). Combined with Progesterone (HY-N0437), 6α-Fluorotestosterone induces lordosis behavior in ovariectomized female rats. 6α-Fluorotestosterone can be used in studies related to anovulatory infertility and sexual behavior regulation .
loading...
    loading...
Cat. No.: HY-P0284B
Target:  

MMP

Research Areas:  

Metabolic Disease

C-telopeptide acetate is a cross-linked peptide of type I collagen that is released during bone resorption and correlates with bone mineral density (BMD). C-telopeptide acetate can be used in studies related to postmenopausal osteoporosis .
loading...
    loading...
Cat. No.: HY-122075
CAS No.: 112856-39-0
Target:  

Others

Research Areas:  

Metabolic Disease

FR 78844 is an orally active bone resorption inhibitor. FR 78844 attenuates metaphyseal bone mineral density decreases in Streptozotocin (HY-13753)-induced diabetic rats, and Heparin (HY-17567A)-induced osteopenia, but does not affect vitamin D-deficient rat bone loss. FR 78844 can be used for the research of osteopenia .
loading...
    loading...
Cat. No.: HY-N21981
CAS No.: 87095-76-9
1,7-Diphenyl-6 (E)-hepten-3-ol is a diarylheptane compound that can be isolated from Curcuma comosa. 1,7-Diphenyl-6 (E)-hepten-3-ol effectively inhibits the motility of Caenorhabditis elegans, thereby causing paralysis or death of the nematodes as a nematicide. 1,7-Diphenyl-6 (E)-hepten-3-ol can be used in studies related to nematode infections .
loading...
    loading...
Cat. No.: HY-107076
CAS No.: 554429-88-8
Research Areas:  

Endocrinology

Estrogen receptor modulator 14 is a chromene-derived prodrug of selective Estrogen Receptor modulator with oral activity. Estrogen receptor modulator 14 undergoes hydrolysis in vivo to produce the active metabolite 2d-(R), which acts on ERα and ERβ. Estrogen receptor modulator 14 acts on central thermoregulatory sites and possesses the ability to regulate estrogen signaling in multiple systemic tissues. Estrogen receptor modulator 14 maintains antiestrogenic activity in the uterus, and alters plasma cholesterol and bone metabolism. Estrogen receptor modulator 14 can be used for the research of estrogen receptor-related diseases .
loading...
    loading...
Cat. No.: HY-N20642
CAS No.: 152110-04-8
Humilinolide A is a limonoid compound. Humilinolide A can be isolated from Swietenia humilis. Humilinolide A binds to estrogen-dependent receptors on the plasma membrane of the myometrium, thereby triggering uterine contraction responses. Humilinolide A induces irreversible, concentration-dependent increases in the tension, amplitude and frequency of smooth muscle contraction. Humilinolide A inhibits radicle growth of barnyard grass (Echinochloa crus-galli) with a IC50 of 99.0 µg/mL. Humilinolide A exhibits antifeedant activity. Humilinolide A can be used in studies related to gastrointestinal motility regulation and reproductive smooth muscle function .
loading...
    loading...
Cat. No.: HY-135529
CAS No.: 63619-84-1
Synonyms: LY133314 free base
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

Trioxifene (LY133314 free base) is an orally active and selective estrogen receptor (ER) modulator with human ERα IC50 of 203.49 nM and Ki of 20.84 nM. Trioxifene binds estradiol receptors, inhibits ERα-mediated gene expression, reduces circulating gonadotrophin levels. Trioxifene can be used for the research of advanced breast cancer and androgen-independent, metastatic prostatic adenocarcinoma .
loading...
    loading...